Cite

    Tapan M Kadia et al.. “Venetoclax plus intensive chemotherapy with cladribine, idarubicin, and cytarabine in patients with newly diagnosed acute myeloid leukaemia or high-risk myelodysplastic syndrome: a cohort from a single-centre, single-arm, phase 2 trial.” Lancet, vol. 8, no. 8, 2021, pp. e552–e561. http://access.bl.uk/ark:/81055/vdc_100136723067.0x000007